Improvements in chronic peripancreatic adipose tissue inflammation, leptin, hyperinsulinemia, T2DM, KRAS activation, IGF and intestinal microbiome after dietary intervention and bariatric surgery may explain the decreased development of pancreatic ductal adenocarcinoma after bariatric surgery [116]. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.